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Neural circuitry and brain activity depend critically on
proper function of voltage-gated calcium channels
(VGCCs), whose activity must be tightly controlled.
We show that the main body of the pore-forming a1
subunit of neuronal L-type VGCCs, Cav1.2, is
proteolytically cleaved, resulting in Cav1.2 fragment
channels that separate but remain on the plasma
membrane. This ‘‘midchannel’’ proteolysis is regu-
lated by channel activity, involves the Ca2+-depen-
dent protease calpain and the ubiquitin-proteasome
system, and causes attenuation and biophysical
alterations of VGCC currents. Recombinant Cav1.2
fragment channels mimicking the products of mid-
channel proteolysis do not form active channels on
their own but, when properly paired, produce cur-
rents with distinct biophysical properties. Mid-
channel proteolysis increases dramatically with age
and can be attenuated with an L-type VGCC blocker
in vivo. Midchannel proteolysis represents a novel
form of homeostatic negative-feedback processing
of VGCCs that could profoundly affect neuronal
excitability, neurotransmission, neuroprotection,
and calcium signaling in physiological and disease
states.
INTRODUCTION
Voltage-gated calcium channels (VGCCs; L, N, P/Q, R, and T
types) control a plethora of physiological processes, from
muscle contraction, heartbeat, neural communication, and
hormone secretion to cell differentiation, motility, growth, and
apoptosis (Catterall, 2000). Their mutations and dysfunction
are linked to diverse disorders, such as epilepsy, migraine,
ataxia, hypertension, arrhythmia, and autism (Cain and Snutch,
2011; Liao and Soong, 2010; Pietrobon, 2010; Striessnig et al.,
2010; Zamponi et al., 2010). In neurons, L-type VGCCs regulate
membrane excitability, Ca2+ signaling, and gene transcription(Catterall, 2000; Deisseroth et al., 2003; Dolmetsch, 2003;
Wheeler et al., 2012). Changes in L-type VGCC activity are linked
to aging and age-related neurodegenerative diseases (Moyer
et al., 1992; Thibault and Landfield, 1996; Thibault et al., 1998),
and variations in L-type VGCC genes are linked to neuropsychi-
atric diseases including schizophrenia, bipolar disorder, autism
spectrum disorder, major depressive disorder, and attention
deficit-hyperactivity disorder (Smoller et al., 2013).
To serve their vital and varying roles, VGCCs are subject to
tight regulation by diverse pathways and mechanisms (Catterall,
2000; Zamponi and Currie, 2013). One form of regulation is
proteolytic processing of the cytosolic C terminus (Ct) of the a1
subunit (Cava1) of L-type VGCCs (Brawley and Hosey, 1992;
De Jongh et al., 1991, 1994; Gao et al., 2001; Gerhardstein
et al., 2000; Hell et al., 1993; Hulme et al., 2005, 2006; Lai
et al., 1990). This proteolysis produces a 30–45 kDa distal
C-terminal fragment, which acts as an autoinhibitory domain
(Hulme et al., 2006). Relief of this autoinhibition is believed to
underlie the sympathetic nerve stimulation-induced increase of
cardiac and skeletal muscle calcium currents, part of the ‘‘fight
or flight’’ response (Fuller et al., 2010). In addition to this Ct frag-
ment, a spectrum of other fragments has been observed in west-
ern blots of L-, N-, and P/Q-type Cava1 (Kordasiewicz et al.,
2006; Leenders et al., 2002, 2008; Ramakrishnan et al., 2006;
Sakurai et al., 1995; Schiff et al., 2000; Scott et al., 1998; West-
enbroek et al., 1995; Woppmann et al., 1994); the most consis-
tent and prominent include 90 kDa, 150 kDa, and 170 kDa
fragments. These fragments have generally been thought to be
nonspecific degradation products. Intriguingly, however, short
isoforms of L- and P/Q-type Cava1 have been found in neurons
and muscle cells (Malouf et al., 1992; Okagaki et al., 2001; Scott
et al., 1998). Moreover, truncated P/Q-type Cava1, generated by
disease-causing mutations, are present in neurons (Jeng et al.,
2008; Mezghrani et al., 2008; Page et al., 2004; Pietrobon,
2010; Scott et al., 1998; Wappl et al., 2002).
VGCCs are typically composed of a pore-forming Cava1 and
auxiliary a2d and b (Cavb) subunits. Full-length Cava1 is a large
protein (with a predicted molecular mass of 190–280 kDa)
consisting of four homologous repeats, each containing six
transmembrane segments; the four repeats are connected by
cytoplasmic loops termed the I-II loop, II-III loop, and III-IV
loop. The aforementioned findings motivated us to investigateNeuron 82, 1045–1057, June 4, 2014 ª2014 Elsevier Inc. 1045
Figure 1. Midchannel Proteolysis of Native Cav1.2 in Cortical Neurons and Its Dependence on Channel Activity
(A) Domain topology of Cav1.2. Indicated are epitope locations for three antibodies (anti-LII-III, anti-Ct, and anti-Nt) and predicted molecular masses for full-length
Cav1.2 and two fragment channels generated by a presumed proteolytic cut (scissors).
(B) Western blot with anti-LII-III of native Cav1.2 in surface-biotinylated (+) and nonbiotinylated () cortical slices from 6-week-old rats, showing a 150 kDa
band (arrow).
(C–E) Western blot with anti-LII-III (C), anti-Ct (D), or anti-Nt (E) of native Cav1.2 from the same sample of surface-biotinylated cortical slices.
(F–I) Channel-activity-dependent regulation of midchannel proteolysis. (F) Verapamil (VP; 65 mM, 2 hr); (G) nifedipine (Nif; 10 mM, 2 hr) and CNQX (21.5 mM, 2 hr);
(H) ionomycin (Iono; 3 mM, 45min); (I) BayK8644 (14 mM, 40min) and 65mMKCl (40min). Left: representative western blot with anti-LII-III of Cav1.2 in cortical slices
treated with either vehicle (control; Ctl) or the indicated reagent(s) before surface biotinylation. Middle: bar graph depicting the proteolysis index (intensity ratio of
the 150 kDa/240 kDa band) for the representative gel. Right: summary graph showing data pooled from the indicated number of independent experiments. In this
and all subsequent figures, data are represented as mean ± SEM, and single and double asterisks denote statistical differences. p < 0.01 by t test.
See also Figure S5.
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Form of Neuromodulation of Ca2+ Channelsthe existence and functional importance of proteolytic cleavage
in the core (i.e., the four repeats and the tethering cytosolic
loops) of Cava1. We find that indeed the core of native brain
L-type Cava1, Cav1.2, undergoes extensive regulated pro-
teolysis, generating Cav1.2 fragments on the plasma membrane
and greatly influencing channel activity. We further find that this
proteolysis is age dependent and can be reversed in vivo by
reducing L-type channel activity. To distinguish this proteolytic
event from C-terminal proteolysis, we refer to it as ‘‘midchannel
proteolysis.’’
RESULTS
Biochemical Detection of Midchannel Proteolysis
of Native L-type Channels
We first studied midchannel proteolysis of native L-type chan-
nels in cortical brain slices freshly isolated from 6-week-old1046 Neuron 82, 1045–1057, June 4, 2014 ª2014 Elsevier Inc.rats. Surface channels were biotinylated and analyzed by
western blot. When probed with an antibody against the
Cav1.2 II-III loop (anti-LII-III; epitope T821–S838 of rat brain
Cav1.2; Figure 1A), two prominent bands were routinely
observed: 240 kDa (full-length Cav1.2) and 150 kDa (Figures
1B–1I). An 85 kDa band was also sometimes detected (Figures
1B–1G). The 150 kDa band was also recognized (Figure 1D,
arrow) by an antibody against the distal C terminus (anti-Ct;
epitope G2127–L2143; Figure 1A). Thus, this fragment appears
to contain part of the II-III loop, repeats III and IV, and the C
terminus (Figure 1A). Anti-Ct also labeled bands at 100 kDa
and 70 kDa (Figure 1D, arrowheads). Probing with an antibody
against the N terminus (anti-Nt; epitope V2–N14; Figure 1A)
also revealed several low molecular weight (MW) bands,
including those at 175 kDa, 100 kDa, and 90 kDa (Figure 1E,
arrowheads and arrow). These results suggest that native
Cav1.2 in cortical neurons undergo extensive proteolysis in vivo
Figure 2. Visualization of Midchannel Proteolysis of Cav1.2 in the Plasma Membrane of Cultured Hippocampal Neurons
(A) Western blot with the indicated antibodies of native Cav1.2 from the same preparation of surface-biotinylated neurons.
(B) Confocal images of a representative dendritic segment of a neuron expressing LGH3. Left: surface and intracellular LGH3 indicated by GFP. Middle: surface
LGH3 indicated by anti-HA+Alexa 594 secondary antibodies. Right: overlay. Exemplar clusters of red/green colocalization and noncolocalization are marked by
yellow and white arrows, respectively. The scale bar represents 5 mm.
(C) Fluorescence intensity profile (bottom) of another dendritic segment (top). Exemplar clusters of red/green colocalization and noncolocalization are marked by
* and **, respectively.
(D) Quantification of red/green colocalization in two dendritic segments displaying visually different extents of midchannel proteolysis. Left andmiddle: images of
GFP (lane 1), HA-Alexa 594 (lane 2), overlay (lane 3), and the voxels selected according to our analysis protocol (lane 4). Right: cumulative distribution of the NCI
for the two selected dendritic segments. The scale bar represents 10 mm.
(E) Ensemble cumulative distribution of the NCI from the dendrites of neurons expressing LGH3 randomly divided into two groups (n = 15 each, same culture).
(F) Ensemble cumulative distribution of the NCI from the dendrites of neurons expressing LGH1 (n = 23), LGH2 (n = 15), and LGH3 (n = 13). All experiments were
performed in parallel. The three distributions were significantly different. p < 0.01 by t test.
See also Figures S1 and S2.
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Form of Neuromodulation of Ca2+ Channelsand that the cleaved products reside in the plasmamembrane as
fragment channels. The 150 kDa fragment detected by both anti-
LII-III and anti-Ct (Figures 1C and 1D, arrows) and the 90 kDa frag-
ment detected by anti-Nt (Figure 1E, arrow) are complementary,
adding up to 240 kDa (expected full-length Cav1.2 MW). As the
150 kDa fragment was the most robust, we focused subsequent
studies on this fragment.
Midchannel Proteolysis Is Bidirectionally Regulated
Wenext investigated whether Cav1.2midchannel proteolysis is a
regulated event occurring in vivo. To minimize nonspecific
degradation, abundant protease inhibitors were added and all
procedures were performed rapidly at 4C. More critically, as
nonspecific degradation is an unregulated event, we investi-
gated whether midchannel proteolysis could instead be disrup-
ted or enhanced. Agents that affect intracellular Ca2+, L-type
channel activity, and/or cell excitability were used to treat
cortical slices prior to surface biotinylation. To quantify midchan-
nel proteolysis, densitometry was used to define a proteolysis in-
dex as the intensity ratio of the 150 kDa/240 kDa bands detected
by anti-LII-III. This index is unaffected by the total protein amount
since it is the ratio of two bands from the same lane/sample. The
nonnormalized proteolysis index differed among preparations
(Figures 1F–1I), reflecting intrinsic animal-to-animal variation.However, this variation does not affect pairwise comparison of
control and test results, whichwere obtained fromparallel exper-
iments from the same animal.
Midchannel proteolysis was decreased by the L-type channel
antagonist verapamil (Figure 1F) or by an activity-suppressing
cocktail of nifedipine (another L-type channel antagonist) and
the glutamate receptor inhibitor 6-cyano-7-nitroquinoxaline-
2,3-dione (CNQX) (Figure 1G). In contrast, midchannel proteoly-
sis was increased by the Ca2+ ionophore ionomycin (Figure 1H)
and by an activity-enhancing cocktail of high extracellular K+
and L-type channel agonist BayK8644 (Figure 1I). Thus, mid-
channel proteolysis correlated with L-type channel activity and
intracellular Ca2+ levels. This bidirectional regulation suggests
that Cav1.2 midchannel proteolysis takes place in vivo.
Regulated midchannel proteolysis of native Cav1.2 was also
observed in cultured hippocampal neurons (Figure 2A; Fig-
ure S1A available online). After surface biotinylation and western
blot, anti-LII-III robustly detected bands at 240 kDa and 150 kDa
(Figure 2A, left, arrow). Both bandswere also detected by anti-Ct
(Figure 2A, middle, arrow), as were a 100 kDa band and a 70 kDa
band (arrowheads), which were also present in cortical slices
(Figure 1D, arrowheads). In the same samples, anti-Nt visualized
the 240 kDa band and a 90 kDa band (Figure 2A, right, arrow).
The detection of the complementary 150 kDa and 90 kDa bandsNeuron 82, 1045–1057, June 4, 2014 ª2014 Elsevier Inc. 1047
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consistent with proteolysis in the II-III loop of Cav1.2.
Visualization of Midchannel Proteolysis Reveals
Separation of Cleaved Fragment Channels
The above biochemical results indicate that the complementary
150 kDa and 90 kDa Cav1.2 fragments are present on the plasma
membrane. Do these cleaved fragments remain associated on
the cell surface? To address this question, we transfected
cultured hippocampal neurons with LGH3, a Cav1.2 tagged
with GFP on the N terminus and hemagglutinin epitope tag
(HA) on an extracellular loop of repeat III (Figure S1B), and visu-
alized the channels by confocal microscopy. LGH3 generated
currents in Xenopus oocytes (Figure S1C) and expressed
robustly in cultured hippocampal neurons (Figure S2). Labeling
the HA tag with an anti-HA antibody and Alexa 594 under non-
permeabilizing conditions revealed LGH3 on the plasma mem-
brane (Figure S2A, red). Cav1.2 with GFP but without the HA
tag (LGN) showed no surface labeling (Figure S2B), indicating
that the anti-HA labeling was specific.
In optical sections, Alexa 594-labeled dendrites of LGH3-
expressing neurons often displayed a membrane-associated
pattern (Figure 2B, middle), consistent with red labeling repre-
senting surface Cav1.2. Surface Cav1.2 channels tend to form
clusters (Figures 2B and 2C), as has been reported (Di Biase
et al., 2011). Intriguingly, in some locations, green and red
clustered separately (Figure 2B, left and Figure 2C). Green-only
clusters likely represent intracellular LGH3 and are expected,
but red-only clusters are anomalous—in theory, GFP and HA
signals should colocalize since the two tags are on the same pro-
tein. The separation of red and green, however, is consistent with
cleavage of Cav1.2 somewhere between the two tags. Further-
more, it suggests that the cleavage products on the plasma
membrane dissociate from one another.
We developed an unbiased procedure to quantify red/green
separation in imaging experiments: (1) a software routine
scanned optical sections of dendrites and automatically
detected red ‘‘voxels,’’ each with a dimension of 0.211 3
0.211 3 0.211 mm (typical dendrites are <2 mm in diameter),
and 10,000 voxels were typically found per neuron; (2) the
intensity of red and green for each voxel was measured; and
(3) the red/green ratio, termed the noncolocalization index
(NCI), was calculated, binned, and graphed in a cumulative
frequency (ordinate) versus NCI (abscissa) plot (Figures 2D–2F).
Three conclusions apply to the results of this analysis protocol:
(1) voxels of high NCI are likely proteolysis hot spots and contain
proteolytically cleaved, HA-containing fragment channels,
including the 150 kDa fragment; (2) the higher the NCI, the
more extensive the proteolysis; and (3) a shift of the distribution
curve to the right signifies greater proteolysis.
The above analysis protocol was calibrated in two dendritic
segments selected for their different extent of red/green separa-
tion (Figure 2D). As expected, the segment displaying a higher
number of visual red-only spots (segment y) showed a right-
shifted NCI distribution (Figure 2D). In another critical test,
LGH3-expressing neurons from the same culture randomly
divided into two groups showed identical ensemble NCI distribu-
tions (Figure 2E), strongly validating the analysis protocol.1048 Neuron 82, 1045–1057, June 4, 2014 ª2014 Elsevier Inc.Visualization of Midchannel Proteolysis Suggests
Multiple Cleavage Sites
If red/green separation represents midchannel proteolysis of
Cav1.2, it should decrease when GFP and HA are closer together
on the channel. Moreover, the appearance of multiple Cav1.2
fragments in western blots (Figures 1D, 1E, and 2A) suggests
that there may be more than one cleavage site in the Cav1.2
core domain. To test these predictions, we constructed two
additional GFP/HA double-tagged Cav1.2 subunits named
LGH1 and LGH2 (HA positioned extracellularly on repeat I or II,
respectively). LGH1 and LGH2 produced currents in oocytes
(Figure S1C), confirming they traffic to the plasma membrane
and are functional. Parallel imaging experiments showed
markedly reduced red/green separation as the two tags were
moved closer together (Figure 2F). These results further validate
the analysis protocol and support the notion that red/green sep-
aration is indicative ofmidchannel proteolysis. They also suggest
proteolysis not only in the II-III loop but also in the I-II loop.
Molecular Determinants of Midchannel Proteolysis
To examine the signaling pathways of midchannel proteolysis,
we first tested the role of calpain, a Ca2+-sensitive protease likely
responsible for the cleavage of the Cav1.2 C terminus (Hell et al.,
1996; Hulme et al., 2006). A cocktail of calpain inhibitors signifi-
cantly reduced midchannel proteolysis in hippocampal neurons,
detected by both western blot and imaging (Figures 3A and 3B),
supporting calpain’s involvement. However, residual midchan-
nel proteolysis persisted (Figure 3A), suggesting additional
proteases. We thus tested the role of the ubiquitin-proteasome
system, a common route for protein degradation. The mid-
channel proteolysis of LGH3wasmarkedly reduced by a cocktail
of ubiquitin aldehyde, a general inhibitor of ubiquitination, and
MG-132, a proteasome inhibitor (Figure 3C), and by mutating a
putative ubiquitination motif on LGH3 (Figure 3D). Two PEST
([proline, glutamic acid, serine, and threonine]-rich) sequences
have been found in Cav1.2, in the I-II and II-III loops (Catalucci
et al., 2009) (named PEST1 and PEST3, respectively; Figure 3E);
PEST sequences serve as signals for rapid proteolysis and
possible degradation by the ubiquitin-proteasome system in
various proteins (Rechsteiner and Rogers, 1996). Midchannel
proteolysis was greatly reduced by PEST3 deletion (Figure 3F)
and was virtually abolished by PEST1 deletion (Figure 3G; Fig-
ure S3C). These results identify structural elements regulating
midchannel proteolysis and suggest a compelling role for the
ubiquitin-proteasome system.
Separation of Fragment channels Is Regulated by
Channel Activity
Midchannel proteolysis of LGH3, like that of endogenous Cav1.2,
was regulated by L-type channel activity. Depolarizing neurons
with high extracellular K+, in the absence or presence of
BayK8644, increased midchannel proteolysis in both imaging
and western blot experiments (Figures 4A and 4B). On the other
hand, treatment with nifedipine, even in the presence of high
extracellular K+, decreased it (Figures 4C and 4D; Figure S4).
These results further support the notion that the red/green
separation is a consequence and manifestation of midchannel
proteolysis.
Figure 3. Signaling Pathways and Molecular Determinants of Cav1.2 Midchannel Proteolysis
(A) Role of calpain. Left: representative western blot with anti-LII-III in hippocampal neurons treated, before surface biotinylation, with a cocktail of calpain
inhibitors (200 nM calpeptin, 1 mMN-acetyl-Leu-Leu-Norleu-al, and 270 nM calpain inhibitor III) for 80min at 37C.Middle: proteolysis index for the representative
gel. Right: summary graph showing data pooled from four independent experiments. p < 0.05 by t test.
(B) Ensemble cumulative distribution of the NCI from the dendrites of neurons expressing LGH3 treated with DMSO (control; n = 24) or calpain inhibitors (n = 19).
p < 0.05 by t test.
(C) Ensemble cumulative distribution of the NCI from the dendrites of neurons expressing LGH3 (n = 13) treated with DMSO (control) or a cocktail of MG-132
(7 mM) and ubiquitin aldehyde (1 mM) for 75 min at 37C. p < 0.05 by t test.
(D) Ensemble cumulative distribution of the NCI from the dendrites of neurons expressing LGH3 (n = 16) or LGH3_PY/AA (n = 17), where residues P1364 and
Y1365 of LGH3 were mutated to alanine. p < 0.01 by t test.
(E) Schematic domain topology of LGH3, marking the positions and amino acid sequences of the PEST1 site, PEST3 site, and PY motif.
(F) Ensemble cumulative distribution of the NCI from the dendrites of neurons expressing LGH3 (n = 19) or LGH3_DPEST3 (n = 17), where residues H840–R861 of
LGH3 were deleted. p < 0.05 by t test.
(G) Ensemble cumulative distribution of the NCI from the dendrites of neurons expressing LGH3 (n = 19) or LGH3_DPEST1 (n = 15), where residues D446–D459 of
LGH3 were deleted. Representative dendrites are shown in Figure S3C. p < 0.01 by t test.
In (B)–(D), (F), and (G), all experiments in each panel were performed in parallel. See also Figure S3.
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Form of Neuromodulation of Ca2+ ChannelsFunctional Impact of Midchannel Proteolysis
We next investigated the functional effect of midchannel proteol-
ysis on calcium channel currents in several ways. First, we tested
the long-term effect of two treatments shown to differentially
alter midchannel proteolysis on native VGCC currents in
hippocampal neurons. Incubating neurons with high K+ and
BayK8644 (followed by washout) increased midchannel proteol-
ysis (Figures 4A and 4B) and reduced VGCC currents (Figure 4E),
whereas incubation with nifedipine (followed by washout)
decreased midchannel proteolysis (Figures 4C and 4D) andenhanced VGCC currents (Figure 4F). These results are consis-
tent with a hypothesis that midchannel proteolysis serves to
homeostatically regulate VGCC activity, keeping at bay exces-
sive Ca2+ influx that could have a potential deleterious effect
on neurons.
Second, in another test of the long-term effect of midchannel
proteolysis, we inserted a cleavage motif for the tobacco etch
virus protease (TEVp) in the II-III loop of LGH3 (between D815
and G816, upstream of the anti-LII-III epitope T821–S838), gener-
ating LGH3_TEVp (Figure 5A). Xenopus oocytes expressingNeuron 82, 1045–1057, June 4, 2014 ª2014 Elsevier Inc. 1049
Figure 4. Channel-Activity-Dependent Regulation of Cav1.2 Midchannel Proteolysis and Ca
2+ Channel Currents in Cultured Hippocampal
Neurons
(A and C) Ensemble cumulative distribution of the NCI from the dendrites of neurons expressing LGH3. Neurons were treated for 30 min with DMSO (control),
DMSO and 65 mM KCl, or 1.4 mM BayK8644 and 65 mM KCl (n = 13 for all) in (A), or with DMSO (control) (n = 19), DMSO and 65 mM KCl (n = 14), or 20 mM
nifedipine and 65mMKCl (n = 18) in (C). Representative dendrites are shown in Figure S4A. All experiments in each panel were performed in parallel. In (A), the two
treated groups were significantly different from the control (p < 0.01 by t test) but not from each other; in (C), all three distributions were significantly different (p <
0.01 by t test). The same results were obtained from two other independent cultures.
(B and D) Channel-activity-dependent regulation of midchannel proteolysis. Left: representative western blot with anti-LII-III in neurons treated (1 hr) with DMSO
(Ctl) or BayK8644 (1.4 mM) (B) or nifedipine (10 mM) (D) before surface biotinylation. Middle: proteolysis index for the representative gel. Right: summary graph
showing data pooled from the indicated number of independent experiments. p < 0.01 by t test.
(E and F) Whole-cell Ca2+ channel currents from neurons blindly treated for 30 min with DMSO (Ctl), 65 mMKCl and 1.4 mMBayK8644 (E), or 10 mMnifedipine (F).
Left: representative family of currents recorded from the indicated neuron. Right: summary graph of the maximal current density for the indicated group of
neurons. The number of blind recordings is indicated above the bar. p < 0.05 by t test.
See also Figure S4.
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Form of Neuromodulation of Ca2+ ChannelsLGH3, LGH3_TEVp, or LGH3 with TEVp had comparable
currents (Figure 5B, top), but those expressing LGH3_TEVp
with TEVp had much smaller currents (Figure 5B, top). The latter
group showed a prominent 150 kDa fragment detected by
anti-LII-III on the plasma membrane, with a drastic concomitant
reduction of the 270 kDa (Cav1.2+27 kDa GFP) full-length band
(Figure 5B, bottom). This 150 kDa fragment, largely absent in
the three control groups, most likely represents the C-terminal
product of specific TEVp cleavage of LGH3_TEVp. The
decreased current of LGH3_TEVp by TEVp proteolysis validates
the hypothesis that midchannel proteolysis downregulates
VGCC currents.
Third, we examined the acute effect of midchannel proteoly-
sis. To accomplish this, we engineered TEVp cleavage sites in
the I-II and II-III loops of Cav2.1 (this mutant is called
Cav2.1_TEVp), and tested the effect of purified recombinant
TEVp on Cav2.1_TEVp channels in inside-out membrane macro-
patches excised from Xenopus oocytes. Cav2.1 was chosen
because its currents run down much more slowly than Cav1.2
currents do. A 2 min application of TEVp did not abolish channel
activity, but did produce an irreversible left shift of the activation
curve of Cav2.1_TEVp but not WT Cav2.1 channels (Figure 5C,1050 Neuron 82, 1045–1057, June 4, 2014 ª2014 Elsevier Inc.bottom). A catalytically inactive TEVp (carrying the C151A muta-
tion) had no effect (Figure 5C, bottom). These results indicate
that midchannel proteolysis alters VGCC gating, leaving a
biophysical imprint.
Fourth, we constructed three pairs of complementary Cav1.2
fragment channels, mimicking midchannel proteolysis in loop
I-II, II-III, or III-IV (Figure 6A), and tested their activity in oocytes
by two-electrode voltage clamp. None of the six recombinant
fragment channels, named A1, A2, B1, B2, C1, and C2, pro-
duced currents when individually expressed in oocytes (Fig-
ure 6B). However, all three complementary pairs produced
sizeable currents, albeit their amplitude was smaller than that
of Cav1.2 currents (Figure 6C). Channels formed by all three
complementary pairs displayed a right-shifted current-voltage
(I-V) curve (Figure 6D) and a change in the voltage dependence
of inactivation (Figure 6E). Thus, although individual fragment
channels do not conduct current, when properly paired they
can assemble and reach the plasma membrane to form func-
tional channels with distinct biophysical properties. We also
examined expression of four noncomplementary fragment pairs,
A1+C2, A2+B1, A2+C1, and B2+C1, in oocytes. The first three
pairs did not produce any currents, while the last pair produced
Figure 5. Functional Effect of Midchannel Cleavage at an Engineered Site on Ca2+ Channel Currents and Properties
(A) Schematic of LGH3_TEVp, which contains a TEVp cutting site (yellow circle) in the II-III loop between D815 and G816, upstream of the anti-LII-III epitope T821–
S838.
(B) Whole-cell currents (top) recorded at 10 mV from oocytes expressing the indicated constructs (middle). Currents were normalized to the mean value of the
leftmost control group. The number of measurements is indicated above the bars. p < 0.01 by t test. Bottom: western blot with anti-LII-III of surface-biotinylated
oocytes from the exact same groups.
(C) Voltage dependence of activation of currents recorded from inside-out macropatches excised from oocytes expressing Cav2.1_TEVp or WT Cav2.1, before
(top) or after (bottom) bath application of 100 mM purified TEVp or TEVp(C151A). Standard error is smaller than the symbols (n = 7–10).
See also Figure S6A.
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repeats of Cava1 are needed to form functional channels and
that certain noncomplementary Cava1 fragments containing,
altogether, more than four repeats may still assemble and form
functional channels, albeit poorly.
Lastly, we examined whether the recombinant fragment chan-
nels change the properties of full-length Cav1.2. Previous studies
have shown that coexpression of Cava1 fragments with full-
length Cava1 often suppresses WT channel currents in a domi-
nant-negative manner and sometimes alters their biophysical
properties (Ebihara et al., 2002; Jeng et al., 2008; Mezghrani
et al., 2008; Page et al., 2004, 2010; Raghib et al., 2001; Raike
et al., 2007). We found that fragment C2 greatly dampened
Cav1.2 current amplitude, while other fragments did not have a
significant dominant-negative effect (Figure 6F). Fragments A1
and A2 shifted the Cav1.2 I-V curve to the right (Figure 6G) and
increased Cav1.2 inactivation (Figure 6H). Fragments B1 and
B2 did not have a significant effect (Figures 6I and 6J). Fragment
C1 shifted Cav1.2’s I-V curve to the left (Figure 6K) and markedly
increased Cav1.2 inactivation (Figure 6L). Thus, Cav1.2 fragment
channels can have multifaceted effects on full-length Cav1.2
channels.
Midchannel Proteolysis Is Age Dependent and Can Be
Reversed In Vivo
Because changes in L-type Ca2+ channel activity have been
linked to normal aging (Moyer et al., 1992; Thibault and Land-
field, 1996; Thibault et al., 1998), we examined whether mid-
channel proteolysis of Cav1.2 is regulated across the lifespan.
Cortical slices were freshly isolated, in strict parallel, from rats
of four age groups (10 days, 6 weeks, 6 months, and 16months),and cell-surface Cav1.2 was examined by western blot
(Figure 7A). Midchannel proteolysis increased steadily and
significantly with age, being approximately seven times more
pronounced in 16-month-old rats than in 10-day-old rats (Fig-
ure 7A). Moreover, the elevated midchannel proteolysis in the
16-month-old rats could be partially reversed by a 3- to
5-week treatment with verapamil, an L-type VGCC blocker
commonly used for hypertension, cardiac arrhythmia, cluster
headache, and bipolar disorder (Figure 7B), at a dosage equiva-
lent to that used for human patients, adjusted for body weight
and metabolic rate.
DISCUSSION
We have uncovered a form of regulation of L-type VGCCs,
namely, proteolytic cleavage of the main body of native Cav1.2
channels. Strikingly, cleaved fragment channels are present on
the plasma membrane and can dissociate from each other.
This midchannel proteolysis is not a result of nonspecific protein
degradation, since it is bidirectionally regulated, inversely corre-
lated with Ca2+ channel activity, and dependent on age. The
finding that midchannel proteolysis in freshly isolated cortical
slices and cultured hippocampal neurons can be reduced by
inhibiting L-type Ca2+ channel activity (Figures 1F, 1G, 4C, and
4D) suggests that it is an ongoing physiological event occurring
in native cells. This finding, together with the observation that
midchannel proteolysis can be enhanced by increased intracel-
lular Ca2+ (Figure 1H; Figure S1A) or increased L-type Ca2+ chan-
nel activity (Figures 1I, 4A, and 4B), suggests that midchannel
proteolysis is a homeostatic/neuroprotective mechanism to
regulate intracellular Ca2+. The dramatic increase of Cav1.2Neuron 82, 1045–1057, June 4, 2014 ª2014 Elsevier Inc. 1051
Figure 6. Functional Properties and Effects of Fragment Channels
(A) Schematic of three possible cuts (scissors) of Cav1.2 and three pairs of recombinant complementary fragment channels.
(B andC)Whole-cell currents recorded at10mV from oocytes expressing the indicated recombinant fragment channels (B) or proper pairs (C). p < 0.01 by t test.
(D and E) Current-voltage relationship (D) and voltage dependence of inactivation (E) of currents recorded from oocytes expressing the indicated constructs.
Standard error is smaller than the symbols (n = 6–18).
(F) Whole-cell currents recorded at 10 mV from oocytes expressing full-length Cav1.2, with or without the indicated recombinant fragment channel coex-
pressed. p < 0.01 by t test.
(G–L) Current-voltage relationship (G, I, and K) and voltage dependence of inactivation (H, J, and L) of currents recorded from oocytes expressing the indicated
Cav1.2 constructs. Standard error is smaller than the symbols (n = 3 for L and n = 6–14 for other panels). The effect of C2 could not be assessed because the
whole-cell current in those experiments was too small to allow accurate measurements (see F, rightmost bar).
See also Figure S6B.
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of such a homeostatic/neuroprotective mechanism: as neurons
age, their L-type Ca2+ channel currents increase (Moyer et al.,
1992; Thibault and Landfield, 1996; Thibault et al., 1998), leading
to increased intracellular Ca2+ and a compensatory increase of
Cav1.2 midchannel proteolysis.
The conditions shown in this study that enhance Cav1.2
midchannel proteolysis, such as increased intracellular Ca2+,
increased Ca2+ channel activity, and increased age, did not
change the levels of surface Na+/K+ ATPases and did not in-
crease proteolysis of poly(ADP-ribose) polymerase (PARP) (Fig-
ure S5), an apoptotic protein marker whose proteolytic cleavage
has been correlated with programmed cell death (Chaitanya1052 Neuron 82, 1045–1057, June 4, 2014 ª2014 Elsevier Inc.et al., 2010), suggesting that midchannel proteolysis of Cav1.2
is not simply an early step of L-type VGCC degradation, not
due to cell damage, and not a prelude to cell death. That mid-
channel proteolysis is robustly detected in freshly isolated
cortical slices and hippocampal neurons (Figures 1, 2, 3, 4 and
7), bidirectionally regulated (Figures 1F–1I and 4A–4D), strongly
linked to aging (Figure 7A), and reversible in animals by an
L-type VGCC blocker (Figure 7B) suggests that midchannel pro-
teolysis is a physiological mechanism of feedback regulation of
L-type VGCCs in intact cells in vivo.
In our imaging experiments, we postulated that the red/green
separation is indicative of midchannel proteolysis of Cav1.2, and
that the lateral shifts of the ensemble NCI plots represent
Figure 7. Midchannel Proteolysis Is Age
Dependent and Can Be Reversed by an
L-type VGCC Blocker In Vivo
(A) Progressive increase of midchannel proteolysis
with age. Left: representative western blot with
anti-LII-III of native Cav1.2 in surface-biotinylated
rat cortical slices from the indicated age groups.
Middle: proteolysis index for the representative
gel. Right: summary graph showing data pooled
from the indicated number of independent
experiments. p < 0.01 by ANOVA. Each indepen-
dent experiment consisted of parallel dissections
of the age groups involved (see Experimental
Procedures).
(B) Reduction of midchannel proteolysis by oral
administration of verapamil. Left: representative
western blot with anti-LII-III of native Cav1.2 in
surface-biotinylated cortical slices from 16-
month-old rats fed with water or water medicated
with 12.5 mg/day of verapamil for 3–5 weeks.
Middle: proteolysis index for the representative
gel. Right: summary graph showing data pooled
from five independent experiments. p < 0.01 by
t test.
See also Figure S7.
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such shifts are due to changes in the relative expression level of
Cav1.2 in the plasma membrane versus intracellular compart-
ments? To examine this possibility, we plotted the ratio of total
red over total green (i.e., surface plus intracellular) fluorescence
for four drug treatments that produced shifts in the NCI: calpain
inhibitors, proteasome inhibitors, 65 mM KCl or 65 mM
KCl+BayK8644, and 65 mM KCl or 65 mM KCl+nifedipine. The
exact same neurons used for the NCI plots were used in the total
fluorescence plots. In each case, the drug treatment did not
significantly change total red/total green fluorescence compared
to its untreated control group (Figures S3A, S3B, S4B, and S4C).
This analysis is consistent with the notion that NCI shifts reflect a
redistribution of red and green in the plasma membrane rather
than a change of intracellular GFP.
Midchannel proteolysis is distinct from the well-studied
C-terminal proteolysis (Brawley and Hosey, 1992; De Jongh
et al., 1991, 1994; Gao et al., 2001; Gerhardstein et al., 2000;
Hell et al., 1993; Hulme et al., 2005, 2006; Lai et al., 1990) in
cleavage sites and consequences: the core of Cav1.2 remains
intact after C-terminal proteolysis but is split following midchan-
nel proteolysis. Our biochemical and imaging experiments both
suggest that midchannel proteolysis takes place at several loca-
tions of Cav1.2 (Figures 1D, 1E, 2A, and 2F). As a result, Cav1.2
channels on the plasmamembrane of native cellsmay be hetero-
geneous, with some being full-length Cav1.2 subunits and some
being Cav1.2 fragments of various lengths. Our results from re-
combinant fragment channels show that they display biophysical
properties distinct from full-length channels (Figures 6C–6E).
Furthermore, our results show that cleaved Cav1.2 fragments
can dissociate from one another (Figures 2B, 2C, and 2F), and
while these fragments do not form functional channels on their
own (Figure 6B), some of them can alter the biophysical
properties of full-length channels (Figures 6F–6L). Thus, Cav1.2
currents in native cells could be produced by a highly heteroge-neous population of channels. How fragment channels change
full-length Cav1.2 properties is unclear; possibilities include
competition for the ancillary subunits (b and/or a2d) or a direct
association with Cav1.2.
VGCCs are regulated by a host of Ca2+-binding proteins and
undergo Ca2+-dependent inactivation (CDI) involving calmodulin
(Christel and Lee, 2012). Why do neurons need yet another Ca2+-
dependent negative-feedback mechanism, and one as drastic
as midchannel proteolysis? For neuroprotection, it is not surpris-
ing if neurons utilize multiple or even redundant means to dili-
gently control the activity of channels as essential as VGCCs.
There may also be significant differences between CDI and mid-
channel proteolysis for neurons to exploit. For example, CDI can
occur quickly to affect VGCC activity within milliseconds
(Tadross et al., 2008; Christel and Lee, 2012); midchannel prote-
olysis, on the other hand, takes longer and may affect not only
VGCC activity but also intracellular Ca2+ homeostasis. Further-
more, while CDI mainly assists VGCC inactivation, the conse-
quences of midchannel proteolysis can involve Ca2+ current
attenuation, channel biophysical property changes, and perhaps
putative nonchannel functions of the nascent fragments.
It has been shown that Cav1.2 and Cav2.2 undergo ubiquitina-
tion and proteasomal degradation, and that these events are
regulated by Cavb (Altier et al., 2011; Waithe et al., 2011). In
the absence of Cavb, Cav1.2 is robustly ubiquitinated and is
targeted to the proteasome for degradation; association of
Cavb attenuates Cav1.2 ubiquitination and prevents endo-
plasmic reticulum (ER)-associated protein degradation (ERAD),
leading to an increased surface expression of Cav1.2 (Altier
et al., 2011). It is unclear whether and how midchannel proteoly-
sis relates to ERAD, but imaging experiments revealed that
separation of proteolytically cleaved Cav1.2 fragments was unal-
tered by the overexpression of a2d and b subunits (Figures S2C
and S2D), suggesting that either these auxiliary subunits do not
affect midchannel proteolysis or that the channels undergoingNeuron 82, 1045–1057, June 4, 2014 ª2014 Elsevier Inc. 1053
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a2d and Cavb subunits.
Where does Cav1.2 midchannel proteolysis take place, on the
plasma membrane or in an intracellular compartment? Although
our results do not provide a definitive answer, they are consistent
with the possibility that midchannel proteolysis occurs on the
plasma membrane: (1) cleaved complementary Cav1.2 frag-
ments are present on the plasma membrane (Figures 1C–1E
and 2A); (2) it is not affected by the overexpression of a2d and
b subunits (Figures S2C and S2D); (3) it is dependent on the
ubiquitin-proteasome system, being greatly reduced by a cock-
tail of ubiquitination and proteasome inhibitors or when a puta-
tive ubiquitination site on Cav1.2 is mutated (Figures 3C and
3D); and (4) it is significantly reduced (Figure 3F) or virtually abol-
ished (Figure 3G) when PEST sequences in Cav1.2 are deleted.
PEST sequences serve as signals for rapid proteolysis by yet un-
known proteases (with calpain as a candidate) or by proteasomal
degradation, presumably by recruiting proper proteases to the
target protein or directing the target protein to proteasomes
(Rechsteiner and Rogers, 1996). It has been reported that the
two PEST sequences in Cav1.2 are involved in Akt-mediated in-
crease of calcium channel currents (Catalucci et al., 2009). Akt is
thought to phosphorylate Cavb2, resulting in the masking of the
PEST sequences and, consequently, decreased degradation of
surface Cav1.2. Consistent with this notion, deleting each
PEST sequence individually increases the stability and current
density of Cav1.2 channels expressed in COS-7 or tsA-201 cells
(Catalucci et al., 2009). The precise role of the two PEST
sequences and why PEST1 is more effective than PEST3 in
aiding Cav1.2 midchannel proteolysis remain to be investigated.
These sequences are probably not the cleavage sites them-
selves. We speculate that PEST1, because of its location and/
or conformation in the three-dimensional structure of Cav1.2, is
more effective than PEST3 in recruiting calpain to Cav1.2.
Many other questions remain to be elucidated, including
the kinetics of midchannel proteolysis, additional proteases
involved, precise cleavage sites in Cava1, and the fate and func-
tion of the resulting fragment channels. It will be interesting to
examine whether other types of VGCCs and other multirepeat
ion channels such as Na+ channels also undergo midchannel
proteolysis. Truncated forms of Cava1, generated by either alter-
native splicing or disease-causing mutations, are naturally pre-
sent in muscles and neurons (Jeng et al., 2008; Malouf et al.,
1992; Mezghrani et al., 2008; Okagaki et al., 2001; Page et al.,
2004; Pietrobon, 2010; Scott et al., 1998; Wappl et al., 2002).
The fragment channels produced by regulated midchannel pro-
teolysis, as well as these short forms of Cava1, may play impor-
tant roles in both physiological and pathological conditions.EXPERIMENTAL PROCEDURES
Constructs
Rat (Rattus norvegicus) brain Cav1.2 was used for transfection in hippocampal
neurons. GFP was linked to the N terminus of Cav1.2 to generate LGN. HA
epitopes were cloned on LGN at different extracellular locations to generate
GFP- and HA-tagged LGH1, LGH2, and LGH3, in which the HA tag was
placed, respectively, between residues T320 and G321, Q683 and T684,
and G1136 and P1137. A proteolytic motif (ENLYFQG) for TEVp was intro-
duced on LGH3 between II-III loop residues D815 and G816 (LGH3_TEVp).1054 Neuron 82, 1045–1057, June 4, 2014 ª2014 Elsevier Inc.On LGH3_PY/AA, P1364 and Y1365 were each mutated to alanine. Residues
840–861 and 446–459 were deleted to generate LGH3_DPEST3 and
LGH3_DPEST1, respectively. Cav1.2 fragment channels were engineered to
encompass the following channel regions: A1: M1–D449, A2: E450–L2143;
B1: M1–S866, B2: M867–L2143; C1: M1–W1216, C2: Y1217–L2143. For
oocyte macropatch recordings, rabbit Cav2.1 was used. Cav2.1_TEVp carried
the TEVp cutting motif at three different locations: G419-A420 (loop I-II),
L1096-S1097, and G1218-P1219 (loop II-III).
Cortical Slice Surface Protein Biotinylation
Neocortical slices (400 mm thick, cut horizontally) were obtained from 6-week-
old male rat brain and were incubated at 35C–37C in oxygenated artificial
cerebrospinal fluid (ACF; 119 mM NaCl, 26 mM NaHCO3, 1.25 mM NaH2PO4,
2.5 mM KCl, 15 mM glucose, 1 mM myo-inositol, 2 mM pyruvate, 0.4 mM
ascorbic acid) for 20–60 min before any pharmacological treatments. For
biotinylation of surface proteins, slices were rapidly collected in ice-cold
bubbled ACF containing 1 mg/ml sulfo-NHS-SS-biotin (Pierce) for 45 min.
Quenching solution was added for 5 min. Solubilization, incubation with
neutravidin-agarose beads, washing, and elution of surface proteins for
SDS-PAGE and western blot were performed according to Pierce’s instruc-
tions, with modifications for neocortical slices described in detail in Supple-
mental Experimental Procedures.
All experiments involving vertebrate animals were performed in accordance
with Columbia University’s Institute of Comparative Medicine and Institutional
Animal Care and Use Committee regulations.
Cortical Slice Age Comparison
For the aging study of Figure 7A, the procedure described above was
upgraded to handle four or more animals of different ages in strict parallel,
as described in detail in Supplemental Experimental Procedures.
Verapamil Feeding of Aged Animals
Verapamil was used to medicate the drinking water of aged rats, at
12.5 mg/day, for 3–5 weeks. Dosage calculation and details of verapamil
administration are explained in Supplemental Experimental Procedures.
Hippocampal Neuron Culture, Transfection, and Surface
Biotinylation
Embryonic hippocampi were isolated and primary cultures were grown using
standard procedures (Blanpied et al., 2002). Twenty-four hours after plating
and then every 4 days, neurobasal medium containing B-27 and I-glutamax
(Invitrogen) was used to replace 50% of the culture medium. Neurons were
kept at 37C in a 5% CO2 humid atmosphere. Hippocampal neurons
10–13 days in vitro were transfected with an optimized method using
Lipofectamine 2000 (Invitrogen). DNA (1.5 mg) in 100 ml Opti-MEM (Invitrogen)
was used to transfect each 12 mm diameter coverslip. Surface biotinylation
was similar to that described for cortical slices.
Hippocampal Neuron Immunofluorescence and Imaging
Hippocampal neurons were fixed with 2% paraformaldehyde and immuno-
stained 24–48 hr posttransfection. To visualize surface HA tags, neurons
were incubated with a mouse monoclonal anti-HA (Covance) for 1 hr in PBS
containing 0.5% fish gelatin and 10% goat serum, and then washed with
PBS four times. The goat anti-mouse secondary antibody conjugated to the
Alexa 594 fluorophore (Invitrogen) was added to the neurons for 1 hr in the
same buffer composition. The stained coverslips were washed and mounted
on imaging slides using an antifade reagent (Biomeda). All procedures were
done at room temperature.
Confocal imaging was performed using a spinning disc microscope. Optical
slice thickness was 300 nm. Confocal images for each fluorophore in multilab-
eling experiments were acquired separately (sequential scans). Images were
analyzed using Volocity (PerkinElmer) and MATLAB (MathWorks).
Imaging Data Quantification and Histogram Construction
A software routine was created to scan optical sections of dendrites and auto-
matically select the red objects, which presumably represent surface Cav1.2.
These objects vary in size and are divided into a volume unit called the voxel,
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0.00944 mm3. Typically, 10,000–15,000 voxels were generated for each
neuron. The red and green intensity was measured for each voxel and the
red/green ratio (i.e., NCI) was determined. The NCI of all the voxels was binned
and plotted in a frequency (ordinate, y axis) versus NCI (abscissa, x axis) graph.
This resulting distribution (curve) shows the percentage of voxels that exhibit
the NCI above a threshold value.
In ensemble % frequency above threshold versus NCI curves using data
pooled from multiple neurons, the x axis consisted of step thresholds used
to bin the entire population of NCI values. Typically, a group of 15 neurons
produced 150,000–200,000 voxels. x axis thresholds were a sequence of
logarithmically spaced numbers generated by MATLAB to represent values
between 0.1 and 10 (listed in Supplemental Experimental Procedures). y axis
data points from all the neurons in any given group were averaged and plotted.
Xenopus Oocyte Preparation, Injection, and Surface Biotinylation
Female oocyte-positive Xenopus laevis (African clawed) frogs were purchased
from Xenopus I, Xenopus Express, or Nasco, and stage V-VI oocytes were
isolated. Briefly, frogs were anesthetized in a 0.3% tricaine solution. Ovarian
lobes were excised in OR2 (Ca2+-free) solution (82.4 mM NaCl, 2.5 mM KCl,
1 mM MgCl2, 5 mM HEPES) and digested in OR2 supplemented with collage-
nase A (0.2–0.5 mg/ml; Roche) for 2–3 hr at room temperature. Oocytes were
washed and recovered in ND96 solution (96 mM NaCl, 2.5 mM KCl, 1 mM
MgCl2, 5 mM HEPES, 1.8 mM CaCl2, supplemented with penicillin/
streptomycin). mRNA injection and oocyte surface biotinylation protocols
are presented in detail in Supplemental Experimental Procedures.
Electrophysiology
For whole-cell recording of hippocampal neurons, the pipette solution
contained 122 mM CsCl, 10 mM HEPES, 10 mM EGTA, 5 mM MgCl2, 4 mM
MgATP, and 0.4 mM GTP (pH 7.2 adjusted with CsOH). Recording electrodes
had resistances of 2–4 MU. The bath solution contained 115 mMNaCl, 20 mM
tetraethylammonium hydroxide, 5 mM KCl, 2 mM MgCl2, 5 mM BaCl2, 10 mM
HEPES, and 10 mM D-glucose (pH 7.4 adjusted with NaOH). Tetradotoxin
(1 mM) was added before recordings.
For two-electrode voltage-clamp recordings of oocytes, the bath solution
contained 10 mM BaCl2, 5 mM KCl, 60 mM tetraethylammonium hydroxide,
20 mM NaOH, and 5 mM HEPES (pH 7.4 adjusted with methanesulfonic acid).
For inside-out macropatch recordings from oocytes, Cav2.1 (P/Q-type)
channels were used because of their slower rundown (Zhen et al., 2006).
Electrodes had a diameter of 15–30 mm and a resistance of 0.2–0.4 MU
when filled with a solution containing 45 mM BaCl2, 80 mM KCl, and 10 mM
HEPES (pH 7.3 adjusted with KOH). The bath solution contained 125 mM
CsCl, 4 mM NaCl, 10 mM HEPES, 10 mM EGTA (pH 7.3 adjusted with
KOH). The purified WT or mutant TEV proteases were perfused in the bath
solution for 2 min, followed by 1 min of wash.
Data were analyzed with Clampfit (Molecular Devices). All experiments were
performed at 22C–23C.
Western Immunoblotting
Protein samples were run on 8% acrylamide (Bio-Rad) gels or 4%–12% pre-
cast gradient gels (Invitrogen). Electrical transfer to polyvinylidene fluoride
(PVDF) membranes (Bio-Rad) was performed in a standard 25 mM Tris,
192 mM glycine (pH 8.3) buffer supplemented with 0.002% SDS for 90 min
at 90 V at 4C. Membranes were handled in PBS containing 0.2% Tween 20
(PBST). Blocking buffer was 10% newborn calf serum (GIBCO) plus 1% fish
gelatin (Sigma) in PBST. Primary antibodies were used at 1:750–1:1,000 dilu-
tions, and were purchased from Sigma (anti-LII-III and anti-Nt), Cell Signaling
(anti-PARP), and Abcam (anti-Na+/K+ ATPase). Anti-Ct, generated against res-
idues 2155–2171 of rabbit cardiac Cav1.2 (Hulme et al., 2006), was a courteous
gift from W.A. Catterall and R. Westenbroek. Secondary antibody (goat anti-
rabbit, horseradish peroxidase-conjugated; Santa Cruz Biotechnology) was
used at 1:2,000 dilution. Protein bands were visualized using enhanced chem-
iluminescence reagents (Pierce) on X-ray film (Kodak). For stripping and
reprobing of PVDF membranes, the stripping buffer contained 100 mM
b-mercaptoethanol, 2% SDS, and 62.5 mM Tris,HCl (pH 6.8). Coomassie
blue staining was performed using Biosafe Coomassie (Bio-Rad) accordingto the manufacturer’s instructions or using a stain consisting of 0.1%
Coomassie brilliant blue R-250 in 40% MeOH and 1% acetic acid.
Purification of Tobacco Etch Virus Protease
For protein synthesis in Escherichia coli, DE3 bacteria were used for cDNA
transformation and protein expression. The expressed recombinant tobacco
etch virus protease (Addgene plasmid 8827: pRK793) construct contained a
maltose-binding protein (MBP) molecule for enhanced expression, a TEVp
self-cleavage recognition site (ENLYFQG), a His tag, and finally TEVp itself.
Ultimately, TEVp was isolated from transformed DE3 bacteria using a
nickel-bead column system as described in Supplemental Experimental
Procedures. Western blot with an antibody against TEVp (courtesy of Michael
Ehrmann) revealed that the purified TEVp had the expected molecular mass of
TEVp plus the His tag (27 kDa), indicating that the tagged MBP molecule had
been removed from the parent construct by TEVp self-cleavage (Figure S6A).
In contrast, the molecular mass of the purified C151A mutant protease was
significantly higher (70 kDa) than that of WT TEVp (Figure S6A), as expected
for the original MBP-tagged parent construct, confirming the loss of catalytic
activity caused by the C151A mutation.
Statistics
Data are represented as mean ± SEM and asterisks denote statistical
differences throughout. For all statistical tests used and their resulting
p values, see Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and seven figures and can be found with this article online at http://dx.doi.
org/10.1016/j.neuron.2014.04.017.
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